StockData
Nektar Therapeutics logo

Nektar Therapeutics (NKTR) stock

NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 9/30
$34.42−1.49 (-4.15%)

Close on Nov 18, 2026Market cap $1.18BP/E –Yield –

Nektar Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Nektar Therapeutics's market cap was $783.36M on Nov 11, 2026, against $1.28B a year earlier. Over the last 5 years it ranged from $89.16M to $2.49B, with a median of $371.97M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$783.36M-5.7%
2025Dec 31, 2025$830.91M+384.4%
2024Dec 31, 2024$171.54M+60.6%
2023Dec 29, 2023$106.83M-74.8%
2022Dec 30, 2022$424.75M-83.0%
2021Dec 31, 2021$2.49B-18.2%
2020Dec 31, 2020$3.05B-19.6%
2019Dec 31, 2019$3.79B-33.3%
2018Dec 31, 2018$5.69B-39.3%
2017Dec 29, 2017$9.37B+454.4%
2016Dec 30, 2016$1.69B-24.7%
2015Dec 31, 2015$2.24B+12.9%
2014Dec 31, 2014$1.99B+51.0%
2013Dec 31, 2013$1.32B+54.4%
2012Dec 31, 2012$852.69M+33.1%
2011Dec 30, 2011$640.79M–

More Nektar Therapeutics figures

See a number that looks wrong?